Main > A1. CORP. INDEX. An-Az > Apollo EndoSurgery Inc./P C2

---

This data is not available for free

Apollo EndoSurgery Inc./P C2's subsections
2012. 01.04. FDA Clears
2012. 02.06. Financing
2013. 10.29. Allergan>Obesity>Acq.
2014. 06.10. CEO
2017. 08.30. Weight Loss System
2017. 11.27. Suturing System
2019. 09.18. USA FDA 510(k) Clear.
2020. 12.15. USA FDA 510(k) Clear.
2022. 07.13. USA FDA Grants De Novo
2022. 11.29. Acq. By Boston Scienti
Web-Site

Apollo EndoSurgery Inc./P C2's products
This section has no products